AsiaMedic Limited (SGX:505)

AsiaMedic Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.46	5.69	7.99	4.6	6.64	9.47
Short-Term Investments	5	3.99	3.49	4.97	1.98	-
Cash & Short-Term Investments	8.45	9.69	11.48	9.58	8.62	9.47
Cash Growth	-1.69%	-15.61%	19.85%	11.06%	-8.98%	16.39%
Accounts Receivable	4.65	4.8	4.08	2.81	3.01	2.1
Other Receivables	3.27	1.16	0.47	0.05	0.02	0.02
Receivables	7.92	5.96	4.55	2.86	3.03	2.12
Inventory	0.09	0.14	0.32	0.36	0.26	0.25
Prepaid Expenses	0.58	0.26	0.27	0.33	0.29	0.19
Restricted Cash	-	0.3	0.48	0.56	0.91	0.82
Other Current Assets	-	0.62	0.62	0.47	0.43	0.6
Total Current Assets	17.04	16.97	17.71	14.16	13.54	13.46
Property, Plant & Equipment	21.34	22.88	25.96	11.04	8	4.22
Long-Term Investments	2.66	2.45	2.2	2.55	2.19	1.99
Goodwill	-	-	-	0.05	-	0.52
Long-Term Deferred Tax Assets	0.89	0.89	0.89	0.89	-	-
Other Long-Term Assets	-	-	-	0.26	-	-
Total Assets	41.93	43.19	46.75	28.95	23.73	20.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.9	1.37	1.64	2	1.48	1.11
Accrued Expenses	-	2.34	1.72	1.61	1.38	1.6
Current Portion of Long-Term Debt	0.09	0.19	0.2	0.2	-	-
Current Portion of Leases	2.05	2.26	2.15	1.52	0.94	1.2
Current Unearned Revenue	0.65	0.8	0.64	0.86	0.99	1.18
Other Current Liabilities	2.88	1.11	3.04	0.62	0.49	0.36
Total Current Liabilities	7.56	8.07	9.4	6.81	5.27	5.45
Long-Term Debt	-	-	0.19	0.39	-	-
Long-Term Leases	14.47	15.42	18.61	7.31	6.38	4.85
Long-Term Deferred Tax Liabilities	0.02	0.02	0.02	0.02	0.02	0.02
Other Long-Term Liabilities	1.6	1.59	1.61	1.17	1.12	1.12
Total Liabilities	23.65	25.09	29.83	15.7	12.79	11.43

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	33.63	33.39	33.67	33.67	33.28	33.28
Retained Earnings	-17.45	-17.48	-18.85	-19.86	-21.78	-23.96
Treasury Stock	-	-0	-0	-0	-0	-0
Comprehensive Income & Other	0.02	0.14	-0.53	-0.55	-0.56	-0.56
Total Common Equity	16.2	16.05	14.29	13.26	10.94	8.76
Minority Interest	2.07	2.04	2.64	-	-	-
Shareholders' Equity	18.28	18.09	16.92	13.26	10.94	8.76
Total Liabilities & Equity	41.93	43.19	46.75	28.95	23.73	20.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.61	17.87	21.15	9.42	7.32	6.05
Net Cash (Debt)	-8.15	-8.18	-9.67	0.15	1.31	3.43
Net Cash Growth	-	-	-	-88.32%	-61.90%	-16.55%
Net Cash Per Share	-0.01	-0.01	-0.01	0.00	0.00	0.00
Filing Date Shares Outstanding	1,148	1,130	1,155	1,155	1,120	1,120
Total Common Shares Outstanding	1,148	1,130	1,155	1,155	1,120	1,120
Working Capital	9.48	8.9	8.3	7.36	8.27	8.01
Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01
Tangible Book Value	16.2	16.05	14.29	13.21	10.94	8.23
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01
Machinery	-	14.11	14.77	14.81	16.42	16.1
Leasehold Improvements	-	2.89	2.7	3.24	3.86	3.32

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error